IRWD240816P15000
- 4.70
- 0.000.00%
Ironwood Pharmaceuticals Newsroom
Express News | Wells Fargo Maintains Overweight on Ironwood Pharmaceuticals, Lowers Price Target to $12
Craig-Hallum Maintains Buy on Ironwood Pharmaceuticals, Lowers Price Target to $10
Ironwood Pharmaceuticals Analyst Ratings
Ironwood (IRWD) Q2 Earnings & Revenues Fall Shy of Estimates
Express News | Ironwood Pharmaceuticals Inc : Jefferies Cuts Target Price to $12 From $14
Ironwood Pharmaceuticals | 10-Q: Q2 2024 Earnings Report
Ironwood Pharma (IRWD) Gets a Buy From JMP Securities
Ironwood Pharmaceuticals: Hold Rating Amidst Financial and Market Headwinds
Express News | Ironwood Pharmaceuticals Shares Are Trading Lower After the Company Reported Worse-than-expected Q2 Financial Results and Revised Its FY24 Guidance
Ironwood Pharmaceuticals Non-GAAP EPS of $0.00 Misses by $0.14, Revenue of $94.4M Misses by $12.6M
Express News | Ironwood Pharmaceuticals Inc: Sees 2024 Total Revenue $350 Mln - $375 Mln
Earnings Flash (IRWD) IRONWOOD PHARMACEUTICALS Reports Q2 Revenue $94.4M
Earnings Flash (IRWD) IRONWOOD PHARMACEUTICALS Posts Q2 EPS $0.00
Express News | Ironwood Pharmaceuticals Q2 Adjusted Net Income USD 1.508 Million Vs. IBES Estimate USD 23.5 Million
Express News | Ironwood Pharmaceuticals Q2 Basic EPS USD -0.01
Express News | Ironwood Pharmaceuticals Q2 Net Income USD -860 Thousand
Express News | Ironwood Pharmaceuticals Q2 Revenue USD 94.396 Million Vs. IBES Estimate USD 107 Million
Express News | Ironwood Pharmaceuticals Q2 Adjusted Ebitda USD 27.909 Million
Craig-Hallum Maintains Ironwood Pharmaceuticals(IRWD.US) With Buy Rating
Ironwood Pharmaceuticals (NASDAQ:IRWD Shareholders Incur Further Losses as Stock Declines 7.2% This Week, Taking Three-year Losses to 51%